James Fox insider trades: GenMark Diagnostics (GNMK) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 6, 2020 | GNMK | ↑ Buy | 9,000 | $5.50 | $50K | Penashe Holdings Propriety Limited | Mar 10, 2020 (4d) |
| Oct 30, 2015 | GNMK | ↑ Buy | 12,000 | $6.90 | $83K | Penashe Holdings Propriety Limited | Nov 2, 2015 (3d) |
| Jun 9, 2015 | BOTA | ↑ Buy | 70,000 | $1.99 | $139K | Penashe Holdings Pty Ltd. | Jun 11, 2015 (2d) |
| Jun 26, 2012 | GNMK | ↑ Buy | 23,810 | $4.20 | $100K | Fox Superannuation Fund | Jun 28, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James Fox's insider trades
James Fox is a director at GenMark Diagnostics (GNMK). Since Jun 26, 2012, James has reported 4 open-market purchases worth $372K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GNMK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.